Literature DB >> 25186272

Low socioeconomic status is associated with worse lung function in the Danish cystic fibrosis population.

David C Taylor-Robinson1, Karsten Thielen2, Tania Pressler3, Hanne V Olesen4, Finn Diderichsen2, Peter J Diggle5, Rosalind Smyth6, Margaret Whitehead7.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25186272      PMCID: PMC4216452          DOI: 10.1183/09031936.00063714

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


× No keyword cloud information.
To the Editor: Low socioeconomic status is associated with worse lung function and greater risk of death in people with cystic fibrosis (CF) in the UK and USA, but there are no population level studies from other countries [1-4]. A feature of previous analyses of inequalities in lung function in CF by socioeconomic status has been the identification of a lung function deficit in more disadvantaged children, which is evident as soon as spirometry can be routinely undertaken at ∼5–6 years of age [1, 3]. The finding of a fixed lung function deficit in the most deprived children in the early years of life has important policy implications, and suggests that deprivation has a detrimental effect on lung health in the early years of a child’s life [5]. We questioned whether similar patterns were evident in other CF populations, so assessed the effect of socioeconomic status on lung function trajectory measured by forced expiratory volume in 1 s (FEV1) % predicted in the Danish population. Therefore, we undertook a retrospective, longitudinal, cohort study of all children and adults with CF who had contributed lung function measures to the Danish CF registry between 1969 and 2010 who could be linked to the national level administrative registers. Patients attending the two Danish CF centres (Copenhagen and Aarhus) were routinely seen every month in the outpatient clinic for evaluation of clinical status, pulmonary function and microbiology of lower respiratory tract secretions. It is estimated that coverage of CF patients resident in Denmark is almost complete from 1990, when CF care was centralised. This coverage and the unparalleled frequency of measurement make this a unique dataset for epidemiological research [6]. The primary outcome for the analysis was FEV1 % predicted. Pulmonary function tests were performed according to international recommendations [7], measuring FEV1 expressed as % predicted for sex and height using reference equations from Wang et al. [8] or Hankinson et al. [9]. The primary exposure of interest was an individual measure of parental socioeconomic status. Data linkage facilitated collection of data on highest parental education level at birth for each child born with CF, measured using the International Standard Classification of Education (ISCED) score. Individuals were coded as having low socioeconomic status if their highest educated parent had basic school level education up to grade 10 (ISCED 1). We first assessed the association between this binary socioeconomic status measure and the mean FEV1 % predicted profile over time, fitted as a linear time trend with a change point, whilst adjusting for birth cohort, sex and genotype (distribution of ΔF508 alleles) (baseline model). We then added clinical characteristics in the final adjusted model (Pseudomonas aeruginosa status, pancreatic status and CF-related diabetes). We used a mixed effects model with longitudinally structured correlation, previously developed to analyse this dataset [6]. This approach provides a more realistic estimate of the FEV1 % predicted trajectory of people with chronic lung disease by acknowledging the imprecision in individual measurements and the correlation structure of repeated measurements on the same individual over time. We estimated model parameters by maximum likelihood, using generalised likelihood ratio statistics to compare nested models, and Wald statistics to test hypotheses about model parameters [10]. The study was approved by the Danish Data inspectorate (Datatilsynet). The linked dataset contains 65 729 lung function measures (22% low parental education versus 78% high education) on 442 patients (21% low versus 79% high education) seen between 1969 and 2010 in Denmark. The follow-up rates were similar in the two groups. In terms of the characteristics of the population stratified by level of parental education, the distribution of ΔF508 alleles was similar in each group, as was the median age at diagnosis. However, the low parental education group contained a greater proportion of females (42% in the low parental education group versus 51% in the high parental education group), more patients who died during follow-up (24% versus 17%), and more patients who developed chronic P. aeruginosa infection (50% versus 42%) and CF-related diabetes (35% versus 23%). There was no evidence to suggest a non-linear age effect in the longitudinal model; therefore, we modelled the population average as a straight line. The difference in average annual rate of decline FEV1 (% per year) was -0.32 (95% CI -0.57– -0.07)% predicted in the baseline model and -0.30 (95% CI -0.38– -0.22)% predicted comparing low versus high educational status groups. In contrast, the onset of Pseudomonas acquisition was associated with an independent effect size of -0.50 (95% CI -0.57– -0.42) percentage points per year. There was no statistically significant difference in the level of FEV1 % predicted at 6 years of age between different socioeconomic status groups. Overall the low parental educational level was associated with a change in FEV1 % predicted of -0.5 (95% CI -0.58– -0.39) percentage points per year after adjustment for demographic, genetic and clinical factors (fig. 1).
Figure 1–

The effect of socioeconomic status as measured by parental education level on the mean forced expiratory volume in 1 s (FEV1) trajectory in children with cystic fibrosis in Denmark. Trajectories plotted with other covariates remained constant for a person born in the 1988–1998 cohort. ISCED: International Standard Classification of Education.

The effect of socioeconomic status as measured by parental education level on the mean forced expiratory volume in 1 s (FEV1) trajectory in children with cystic fibrosis in Denmark. Trajectories plotted with other covariates remained constant for a person born in the 1988–1998 cohort. ISCED: International Standard Classification of Education. This analysis confirms that people with CF from more disadvantaged backgrounds have worse lung function, even in the context of a well-developed Danish health and welfare system. A key strength is the use of a precisely recorded individual level measure of socioeconomic status, facilitated by data linkage systems in Denmark, and the long period of follow-up. This is the first population level study to clearly demonstrate a difference in the longitudinal rate of decline of lung function in CF on the basis of socioeconomic status, but in contrast to previous studies there was no evidence of a significant social difference at 6 years of age. In the UK people from the most deprived areas have significantly worse lung function (FEV1 % predicted -4.12 (95% C1 -5.01– -3.19) percentage points) at 5 years of age, but the social gap in FEV1 % predicted did not increase over time. By contrast, in the analysis presented here, an equivalent gap of four percentage points between the most and least advantaged groups (on the basis of parental education) develops in Denmark at ∼17 years of age. In the cross-sectional study of US data by Schechter et al. [1], large inequalities in FEV1 % predicted by Medicaid status were evident at 5 years of age (9% difference), and these widened slightly up to 20 years of age. In their longitudinal US study, O’Connor et al. [2] found a difference of 5.5% between the most and least deprived income quintiles, which did not increase significantly over time. There are several possible explanations for the differences between the studies. Methodological differences between these studies mean that direct comparison between the UK, USA and Denmark on the magnitude of the deprivation gap in lung function is inappropriate since the socioeconomic exposure measures used are different. The UK and US studies used area-based measures of deprivation or income, whereas this study used a precise individual level measure of maternal educational status. Furthermore, the high frequency follow-up in this unique Danish dataset has allowed us to fit a more sophisticated model, which we believe leads to more efficient estimation of the rate of lung function decline in Denmark [6]. However, the differences may reflect substantive societal level differences between Denmark, the UK and the USA, or differences in CF care. For instance we can speculate that the Danish welfare system, coupled with lower levels of child poverty, and universal access to high quality healthcare may reduce social differences in outcomes in early childhood [11]. Furthermore, the approach to CF care in Denmark, characterised by monthly follow-up and aggressive treatment of infections, may protect the most disadvantaged in the early years. We can further speculate that the emergence of individual level factors, such as disease self-management, may play more of a role in later life, and may account for the deterioration in lung function seen in more disadvantaged children at older ages in Denmark. Low socioeconomic status can damage lung function in the early years, and can also lead to an increased rate of decline over the longer term. This suggests that environmental and social factors have an important influence on lung function in people with CF, which act across the life course, starting from an early age [3, 12]. Tobacco smoke exposure may be an important mediator of the relationship between socioeconomic status and adverse outcomes in CF, since there are striking and persistent differences in smoking prevalence by socioeconomic status in the general population in Denmark [11] and the UK [5], and environmental tobacco smoke exposure is associated with poorer growth and lung function in CF [13]. Policies should focus on providing additional support to children and adults with CF from more disadvantaged backgrounds over the life course, with a focus on getting things right in the early years [14].
  14 in total

1.  Standardisation of spirometry.

Authors:  M R Miller; J Hankinson; V Brusasco; F Burgos; R Casaburi; A Coates; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; R Jensen; D C Johnson; N MacIntyre; R McKay; D Navajas; O F Pedersen; R Pellegrino; G Viegi; J Wanger
Journal:  Eur Respir J       Date:  2005-08       Impact factor: 16.671

2.  Spirometric reference values from a sample of the general U.S. population.

Authors:  J L Hankinson; J R Odencrantz; K B Fedan
Journal:  Am J Respir Crit Care Med       Date:  1999-01       Impact factor: 21.405

3.  Median household income and mortality rate in cystic fibrosis.

Authors:  Gerald T O'Connor; Hebe B Quinton; Terry Kneeland; Richard Kahn; Thomas Lever; Joanne Maddock; Priscilla Robichaud; Mark Detzer; Donald R Swartz
Journal:  Pediatrics       Date:  2003-04       Impact factor: 7.124

4.  Random-effects models for longitudinal data.

Authors:  N M Laird; J H Ware
Journal:  Biometrics       Date:  1982-12       Impact factor: 2.571

5.  The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States.

Authors:  M S Schechter; B J Shelton; P A Margolis; S C Fitzsimmons
Journal:  Am J Respir Crit Care Med       Date:  2001-05       Impact factor: 21.405

Review 6.  Early lung disease in cystic fibrosis.

Authors:  Hartmut Grasemann; Felix Ratjen
Journal:  Lancet Respir Med       Date:  2013-03-12       Impact factor: 30.700

7.  Pulmonary function between 6 and 18 years of age.

Authors:  X Wang; D W Dockery; D Wypij; M E Fay; B G Ferris
Journal:  Pediatr Pulmonol       Date:  1993-02

8.  Association between socioeconomic status, sex, and age at death from cystic fibrosis in England and Wales (1959 to 2008): cross sectional study.

Authors:  Helen L Barr; John Britton; Alan R Smyth; Andrew W Fogarty
Journal:  BMJ       Date:  2011-08-23

9.  A longitudinal study of the impact of social deprivation and disease severity on employment status in the UK cystic fibrosis population.

Authors:  David C Taylor-Robinson; Rosalind Smyth; Peter J Diggle; Margaret Whitehead
Journal:  PLoS One       Date:  2013-08-23       Impact factor: 3.240

10.  The effect of social deprivation on clinical outcomes and the use of treatments in the UK cystic fibrosis population: a longitudinal study.

Authors:  David C Taylor-Robinson; Rosalind L Smyth; Peter J Diggle; Margaret Whitehead
Journal:  Lancet Respir Med       Date:  2013-01-30       Impact factor: 30.700

View more
  6 in total

Review 1.  Socioeconomic determinants of respiratory health in patients with cystic fibrosis: implications for treatment strategies.

Authors:  Gabriela R Oates; Michael S Schechter
Journal:  Expert Rev Respir Med       Date:  2022-06-23       Impact factor: 4.300

Review 2.  The demographics of adverse outcomes in cystic fibrosis.

Authors:  Meghan E McGarry; Wadsworth A Williams; Susanna A McColley
Journal:  Pediatr Pulmonol       Date:  2019-11

3.  Risk factors for lung function decline in a large cohort of young cystic fibrosis patients.

Authors:  Jonathan Cogen; Julia Emerson; Don B Sanders; Clement Ren; Michael S Schechter; Ronald L Gibson; Wayne Morgan; Margaret Rosenfeld
Journal:  Pediatr Pulmonol       Date:  2015-06-09

Review 4.  Cystic Fibrosis Lung Disease Modifiers and Their Relevance in the New Era of Precision Medicine.

Authors:  Afsoon Sepahzad; Deborah J Morris-Rosendahl; Jane C Davies
Journal:  Genes (Basel)       Date:  2021-04-13       Impact factor: 4.096

5.  From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations.

Authors:  Gudio Veit; Radu G Avramescu; Annette N Chiang; Scott A Houck; Zhiwei Cai; Kathryn W Peters; Jeong S Hong; Harvey B Pollard; William B Guggino; William E Balch; William R Skach; Garry R Cutting; Raymond A Frizzell; David N Sheppard; Douglas M Cyr; Eric J Sorscher; Jeffrey L Brodsky; Gergely L Lukacs
Journal:  Mol Biol Cell       Date:  2016-02-01       Impact factor: 4.138

6.  Repeatability of the 6-min walk test in non-cystic fibrosis bronchiectasis.

Authors:  Paula Maria Eidt Rovedder; Rafael Oliveira Fernandes; Patrícia Santos Jacques; Bruna Ziegler; Francini Porcher Andrade; Paulo de Tarso Roth Dalcin
Journal:  Sci Rep       Date:  2020-11-05       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.